Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

409 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cystic fibrosis and noninvasive liver fibrosis assessment methods in children.
Enaud R, Frison E, Missonnier S, Fischer A, de Ledinghen V, Perez P, Bui S, Fayon M, Chateil JF, Lamireau T. Enaud R, et al. Among authors: de ledinghen v. Pediatr Res. 2022 Jan;91(1):223-229. doi: 10.1038/s41390-021-01427-4. Epub 2021 Mar 17. Pediatr Res. 2022. PMID: 33731812
Diagnosis of liver fibrosis by transient elastography (FibroScan) and non-invasive methods in Crohn's disease patients treated with methotrexate.
Laharie D, Zerbib F, Adhoute X, Boué-Lahorgue X, Foucher J, Castéra L, Rullier A, Bertet J, Couzigou P, Amouretti M, de Lédinghen V. Laharie D, et al. Among authors: de ledinghen v. Aliment Pharmacol Ther. 2006 Jun 1;23(11):1621-8. doi: 10.1111/j.1365-2036.2006.02929.x. Aliment Pharmacol Ther. 2006. PMID: 16696812 Free article.
Liver stiffness measurement in children using FibroScan: feasibility study and comparison with Fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy.
de Lédinghen V, Le Bail B, Rebouissoux L, Fournier C, Foucher J, Miette V, Castéra L, Sandrin L, Merrouche W, Lavrand F, Lamireau T. de Lédinghen V, et al. J Pediatr Gastroenterol Nutr. 2007 Oct;45(4):443-50. doi: 10.1097/MPG.0b013e31812e56ff. J Pediatr Gastroenterol Nutr. 2007. PMID: 18030211 Clinical Trial.
[The liver and methotrexate].
Laharie D, Terrebonne E, Vergniol J, Chanteloup E, Chabrun E, Couzigou P, de Lédinghen V. Laharie D, et al. Among authors: de ledinghen v. Gastroenterol Clin Biol. 2008 Feb;32(2):134-42. doi: 10.1016/j.gcb.2007.11.002. Gastroenterol Clin Biol. 2008. PMID: 18494155 Free article. Review. French.
[Non-invasive evaluation of liver fibrosis in hepatitis C].
de Lédinghen V, Poynard T, Wartelle C, Rosenthal E. de Lédinghen V, et al. Gastroenterol Clin Biol. 2008 Mar;32(3 Pt 2):S90-5. doi: 10.1016/S0399-8320(08)73271-8. Gastroenterol Clin Biol. 2008. PMID: 18675186 Free article. Review. French.
Validation and comparison of simple noninvasive indexes for predicting liver fibrosis in HIV-HCV-coinfected patients: ANRS CO3 Aquitaine cohort.
Loko MA, Castera L, Dabis F, Le Bail B, Winnock M, Coureau G, Bioulac-Sage P, de Ledinghen V, Neau D; Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA). Loko MA, et al. Among authors: de ledinghen v. Am J Gastroenterol. 2008 Aug;103(8):1973-80. doi: 10.1111/j.1572-0241.2008.01954.x. Am J Gastroenterol. 2008. PMID: 18796094 Free article.
Transient elastography (FibroScan).
de Lédinghen V, Vergniol J. de Lédinghen V, et al. Gastroenterol Clin Biol. 2008 Sep;32(6 Suppl 1):58-67. doi: 10.1016/S0399-8320(08)73994-0. Gastroenterol Clin Biol. 2008. PMID: 18973847 Free article.
Usefulness of noninvasive tests in nodular regenerative hyperplasia of the liver.
Laharie D, Vergniol J, Bioulac-Sage P, Diris B, Poli J, Foucher J, Couzigou P, Drouillard J, de Lédinghen V. Laharie D, et al. Among authors: de ledinghen v. Eur J Gastroenterol Hepatol. 2010 Apr;22(4):487-93. doi: 10.1097/MEG.0b013e328334098f. Eur J Gastroenterol Hepatol. 2010. PMID: 19940782
On the validity of meta-analyses: exhaustivity must be warranted, exclusion of duplicate patients too.
Pambrun E, Bouteloup V, Thiébaut R, Asselineau J, de Lédinghen V, Perez P; Steering Committee of the Transient Elastography Individual Patient Data meta-analysis Study (TE IPD Study). Pambrun E, et al. Among authors: de ledinghen v. J Clin Epidemiol. 2010 Mar;63(3):342-3. doi: 10.1016/j.jclinepi.2009.07.021. Epub 2010 Jan 15. J Clin Epidemiol. 2010. PMID: 20079606 No abstract available.
Assessment of liver fibrosis with transient elastography and FibroTest in patients treated with methotrexate for chronic inflammatory diseases: a case-control study.
Laharie D, Seneschal J, Schaeverbeke T, Doutre MS, Longy-Boursier M, Pellegrin JL, Chabrun E, Villars S, Zerbib F, de Lédinghen V. Laharie D, et al. Among authors: de ledinghen v. J Hepatol. 2010 Dec;53(6):1035-40. doi: 10.1016/j.jhep.2010.04.043. Epub 2010 Aug 12. J Hepatol. 2010. PMID: 20801541
Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: the ANRS HCEP-23 study.
Zarski JP, Sturm N, Guechot J, Paris A, Zafrani ES, Asselah T, Boisson RC, Bosson JL, Guyader D, Renversez JC, Bronowicki JP, Gelineau MC, Tran A, Trocme C, De Ledinghen V, Lasnier E, Poujol-Robert A, Ziegler F, Bourliere M, Voitot H, Larrey D, Rosenthal-Allieri MA, Fouchard Hubert I, Bailly F, Vaubourdolle M; ANRS HCEP 23 Fibrostar Group. Zarski JP, et al. Among authors: de ledinghen v. J Hepatol. 2012 Jan;56(1):55-62. doi: 10.1016/j.jhep.2011.05.024. Epub 2011 Jul 23. J Hepatol. 2012. PMID: 21781944
Liver fibrosis: noninvasive assessment with acoustic radiation force impulse elastography--comparison with FibroScan M and XL probes and FibroTest in patients with chronic liver disease.
Cassinotto C, Lapuyade B, Aït-Ali A, Vergniol J, Gaye D, Foucher J, Bailacq-Auder C, Chermak F, Le Bail B, de Lédinghen V. Cassinotto C, et al. Among authors: de ledinghen v. Radiology. 2013 Oct;269(1):283-92. doi: 10.1148/radiol.13122208. Epub 2013 Apr 29. Radiology. 2013. PMID: 23630312
Quantification of portal-bridging fibrosis area more accurately reflects fibrosis stage and liver stiffness than whole fibrosis or perisinusoidal fibrosis areas in chronic hepatitis C.
Sandrini J, Boursier J, Chaigneau J, Sturm N, Zarski JP, Le Bail B, de Ledinghen V, Calès P, Rousselet MC. Sandrini J, et al. Among authors: de ledinghen v. Mod Pathol. 2014 Jul;27(7):1035-45. doi: 10.1038/modpathol.2013.225. Epub 2014 Jan 3. Mod Pathol. 2014. PMID: 24390214 Free article.
Liver and spleen elastography using supersonic shear imaging for the non-invasive diagnosis of cirrhosis severity and oesophageal varices.
Cassinotto C, Charrie A, Mouries A, Lapuyade B, Hiriart JB, Vergniol J, Gaye D, Hocquelet A, Charbonnier M, Foucher J, Laurent F, Chermak F, Montaudon M, de Ledinghen V. Cassinotto C, et al. Among authors: de ledinghen v. Dig Liver Dis. 2015 Aug;47(8):695-701. doi: 10.1016/j.dld.2015.04.008. Epub 2015 Apr 20. Dig Liver Dis. 2015. PMID: 25959234
Liver stiffness in nonalcoholic fatty liver disease: A comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy.
Cassinotto C, Boursier J, de Lédinghen V, Lebigot J, Lapuyade B, Cales P, Hiriart JB, Michalak S, Bail BL, Cartier V, Mouries A, Oberti F, Fouchard-Hubert I, Vergniol J, Aubé C. Cassinotto C, et al. Among authors: de ledinghen v. Hepatology. 2016 Jun;63(6):1817-27. doi: 10.1002/hep.28394. Epub 2016 Jan 22. Hepatology. 2016. PMID: 26659452 Clinical Trial.
Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values.
Petta S, Wong VW, Cammà C, Hiriart JB, Wong GL, Marra F, Vergniol J, Chan AW, Di Marco V, Merrouche W, Chan HL, Barbara M, Le-Bail B, Arena U, Craxì A, de Ledinghen V. Petta S, et al. Among authors: de ledinghen v. Hepatology. 2017 Apr;65(4):1145-1155. doi: 10.1002/hep.28843. Epub 2016 Nov 5. Hepatology. 2017. PMID: 27639088
Assessment of biopsy-proven liver fibrosis by two-dimensional shear wave elastography: An individual patient data-based meta-analysis.
Herrmann E, de Lédinghen V, Cassinotto C, Chu WC, Leung VY, Ferraioli G, Filice C, Castera L, Vilgrain V, Ronot M, Dumortier J, Guibal A, Pol S, Trebicka J, Jansen C, Strassburg C, Zheng R, Zheng J, Francque S, Vanwolleghem T, Vonghia L, Manesis EK, Zoumpoulis P, Sporea I, Thiele M, Krag A, Cohen-Bacrie C, Criton A, Gay J, Deffieux T, Friedrich-Rust M. Herrmann E, et al. Among authors: de ledinghen v. Hepatology. 2018 Jan;67(1):260-272. doi: 10.1002/hep.29179. Epub 2017 Nov 15. Hepatology. 2018. PMID: 28370257 Free PMC article. Review.
Serial combination of non-invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLD.
Petta S, Wong VW, Cammà C, Hiriart JB, Wong GL, Vergniol J, Chan AW, Di Marco V, Merrouche W, Chan HL, Marra F, Le-Bail B, Arena U, Craxì A, de Ledinghen V. Petta S, et al. Among authors: de ledinghen v. Aliment Pharmacol Ther. 2017 Sep;46(6):617-627. doi: 10.1111/apt.14219. Epub 2017 Jul 27. Aliment Pharmacol Ther. 2017. PMID: 28752524
Reply to: "Pitfalls in the non-invasive assessment of liver fibrosis with eLIFT-FMVCTE algorithm" and to "Application of the new eLIFT test for the non-invasive diagnosis of advanced liver fibrosis in people with type 2 diabetes".
Boursier J, de Ledinghen V, Leroy V, Calès P. Boursier J, et al. Among authors: de ledinghen v. J Hepatol. 2018 Mar;68(3):605-606. doi: 10.1016/j.jhep.2017.09.022. Epub 2017 Oct 4. J Hepatol. 2018. PMID: 28987517 No abstract available.
Criteria to Determine Reliability of Noninvasive Assessment of Liver Fibrosis With Virtual Touch Quantification.
Boursier J, Cassinotto C, Hunault G, Shili S, Lebigot J, Lapuyade B, Lannes A, Hiriart JB, Cartier V, Le Bail B, Michalak S, Mouries A, Oberti F, Chermak F, Fouchard-Hubert I, Cales P, Aube C, de Ledinghen V. Boursier J, et al. Among authors: de ledinghen v. Clin Gastroenterol Hepatol. 2019 Jan;17(1):164-171.e5. doi: 10.1016/j.cgh.2018.04.062. Epub 2018 May 9. Clin Gastroenterol Hepatol. 2019. PMID: 29753082
Non-invasive diagnosis of liver fibrosis in patients with alcohol-related liver disease by transient elastography: an individual patient data meta-analysis.
Nguyen-Khac E, Thiele M, Voican C, Nahon P, Moreno C, Boursier J, Mueller S, de Ledinghen V, Stärkel P, Gyune Kim S, Fernandez M, Madsen B, Naveau S, Krag A, Perlemuter G, Ziol M, Chatelain D, Diouf M. Nguyen-Khac E, et al. Among authors: de ledinghen v. Lancet Gastroenterol Hepatol. 2018 Sep;3(9):614-625. doi: 10.1016/S2468-1253(18)30124-9. Epub 2018 Jul 6. Lancet Gastroenterol Hepatol. 2018. PMID: 29983372
Liver Stiffness Measurement With FibroScan: Use the Right Probe in the Right Conditions!
Berger A, Shili S, Zuberbuhler F, Hiriart JB, Lannes A, Chermak F, Hunault G, Foucher J, Oberti F, Fouchard-Hubert I, Cales P, de Ledinghen V, Boursier J. Berger A, et al. Among authors: de ledinghen v. Clin Transl Gastroenterol. 2019 Apr;10(4):e00023. doi: 10.14309/ctg.0000000000000023. Clin Transl Gastroenterol. 2019. PMID: 31009403 Free PMC article. Clinical Trial.
New sequential combinations of non-invasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD.
Boursier J, Guillaume M, Leroy V, Irlès M, Roux M, Lannes A, Foucher J, Zuberbuhler F, Delabaudière C, Barthelon J, Michalak S, Hiriart JB, Peron JM, Gerster T, Le Bail B, Riou J, Hunault G, Merrouche W, Oberti F, Pelade L, Fouchard I, Bureau C, Calès P, de Ledinghen V. Boursier J, et al. Among authors: de ledinghen v. J Hepatol. 2019 Aug;71(2):389-396. doi: 10.1016/j.jhep.2019.04.020. Epub 2019 May 16. J Hepatol. 2019. PMID: 31102719
Impact of Obesity and Alanine Aminotransferase Levels on the Diagnostic Accuracy for Advanced Liver Fibrosis of Noninvasive Tools in Patients With Nonalcoholic Fatty Liver Disease.
Petta S, Wai-Sun Wong V, Bugianesi E, Fracanzani AL, Cammà C, Hiriart JB, Lai-Hung Wong G, Vergniol J, Wing-Hung Chan A, Giannetti A, Merrouche W, Lik-Yuen Chan H, Le-Bail B, Lombardi R, Guastella S, Craxì A, de Ledinghen V. Petta S, et al. Among authors: de ledinghen v. Am J Gastroenterol. 2019 Jun;114(6):916-928. doi: 10.14309/ajg.0000000000000153. Am J Gastroenterol. 2019. PMID: 31169533 Free article.
Performance of Simple Fibrosis Scores in Nonobese Patients With Nonalcoholic Fatty Liver Disease.
Fu C, Wai JW, Nik Mustapha NR, Irles M, Wong GL, Mahadeva S, Shili S, Chan AW, Merrouche W, Chan HL, Foucher J, Le Bail B, Wong VW, Chan WK, de Lédinghen V. Fu C, et al. Among authors: de ledinghen v. Clin Gastroenterol Hepatol. 2020 Nov;18(12):2843-2845.e2. doi: 10.1016/j.cgh.2019.09.027. Epub 2019 Sep 28. Clin Gastroenterol Hepatol. 2020. PMID: 31574313
Reliability Criteria of Two-Dimensional Shear Wave Elastography: Analysis of 4277 Measurements in 788 Patients.
Paisant A, Lemoine S, Cassinotto C, de Lédinghen V, Ronot M, Irlès-Depé M, Vilgrain V, Le Bail B, Paradis V, Canivet CM, Michalak S, Rousselet MC, Rautou PE, Lebigot J, Hunault G, Crouan A, Aubé C, Boursier J. Paisant A, et al. Among authors: de ledinghen v. Clin Gastroenterol Hepatol. 2022 Feb;20(2):400-408.e10. doi: 10.1016/j.cgh.2020.12.013. Epub 2020 Dec 16. Clin Gastroenterol Hepatol. 2022. PMID: 33340779 Clinical Trial.
Quality criteria for the measurement of liver stiffness.
Boursier J, Decraecker M, Bourlière M, Bureau C, Ganne-Carrié N, de Lédinghen V. Boursier J, et al. Among authors: de ledinghen v. Clin Res Hepatol Gastroenterol. 2022 Jan;46(1):101761. doi: 10.1016/j.clinre.2021.101761. Epub 2021 Jul 27. Clin Res Hepatol Gastroenterol. 2022. PMID: 34325013
Non-invasive diagnosis and follow-up of vascular liver diseases.
Rautou PE, Elkrief L, Decraecker M, Ollivier-Hourmand I, Plessier A, Ronot M, Vilgrain V, Bourlière M, Ganne-Carrié N, de Lédinghen V, Bureau C. Rautou PE, et al. Among authors: de ledinghen v. Clin Res Hepatol Gastroenterol. 2022 Jan;46(1):101764. doi: 10.1016/j.clinre.2021.101764. Epub 2021 Jul 29. Clin Res Hepatol Gastroenterol. 2022. PMID: 34332130
Non-invasive diagnosis and follow-up of chronic liver disease.
de Lédinghen V. de Lédinghen V. Clin Res Hepatol Gastroenterol. 2022 Jan;46(1):101763. doi: 10.1016/j.clinre.2021.101763. Epub 2021 Jul 29. Clin Res Hepatol Gastroenterol. 2022. PMID: 34332138 No abstract available.
Diagnostic and predictive factors of significant liver fibrosis and minimal lesions in patients with persistent unexplained elevated transaminases. A prospective multicenter study.
de Lédinghen V, Ratziu V, Causse X, Le Bail B, Capron D, Renou C, Pilette C, Oules V, Gelsi E, Oberti F, Vallet-Pichard A, Le Provost N, Cadranel JF; Association Française pour l'Etude du Foie Groupe Epidémiologie et Evaluation; Association Nationale des Gastroentérologues des Hôpitaux généraux de France. de Lédinghen V, et al. J Hepatol. 2006 Oct;45(4):592-9. doi: 10.1016/j.jhep.2006.05.008. Epub 2006 Jun 16. J Hepatol. 2006. PMID: 16837098 Clinical Trial.
Evaluating the accuracy and increasing the reliable diagnosis rate of blood tests for liver fibrosis in chronic hepatitis C.
Calès P, de Ledinghen V, Halfon P, Bacq Y, Leroy V, Boursier J, Foucher J, Bourlière M, de Muret A, Sturm N, Hunault G, Oberti F. Calès P, et al. Among authors: de muret a, de ledinghen v. Liver Int. 2008 Dec;28(10):1352-62. doi: 10.1111/j.1478-3231.2008.01789.x. Epub 2008 May 19. Liver Int. 2008. PMID: 18492022 Free PMC article.
Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores.
Castéra L, Le Bail B, Roudot-Thoraval F, Bernard PH, Foucher J, Merrouche W, Couzigou P, de Lédinghen V. Castéra L, et al. Among authors: de ledinghen v. J Hepatol. 2009 Jan;50(1):59-68. doi: 10.1016/j.jhep.2008.08.018. Epub 2008 Oct 26. J Hepatol. 2009. PMID: 19013661
Changes of non-invasive markers and FibroScan values during HCV treatment.
Vergniol J, Foucher J, Castéra L, Bernard PH, Tournan R, Terrebonne E, Chanteloup E, Merrouche W, Couzigou P, de Lédinghen V. Vergniol J, et al. Among authors: de ledinghen v. J Viral Hepat. 2009 Feb;16(2):132-40. doi: 10.1111/j.1365-2893.2008.01055.x. Epub 2008 Oct 17. J Viral Hepat. 2009. PMID: 19175875
Liver fibrosis staging with contrast-enhanced ultrasonography: prospective multicenter study compared with METAVIR scoring.
Staub F, Tournoux-Facon C, Roumy J, Chaigneau C, Morichaut-Beauchant M, Levillain P, Prevost C, Aubé C, Lebigot J, Oberti F, Galtier JB, Laumonier H, Trillaud H, Bernard PH, Blanc JF, Sironneau S, Machet F, Drouillard J, de Ledinghen V, Couzigou P, Foucher P, Castéra L, Tranquard F, Bacq Y, d'Altéroche L, Ingrand P, Tasu JP. Staub F, et al. Among authors: de ledinghen v. Eur Radiol. 2009 Aug;19(8):1991-7. doi: 10.1007/s00330-009-1313-x. Epub 2009 Mar 4. Eur Radiol. 2009. PMID: 19259683 Free article.
Optimization and robustness of blood tests for liver fibrosis and cirrhosis.
Calès P, Boursier J, Bertrais S, Oberti F, Gallois Y, Fouchard-Hubert I, Dib N, Zarski JP, Rousselet MC; multicentric groups (SNIFF 14 & 17, ANRS HC EP 23 Fibrostar). Calès P, et al. Clin Biochem. 2010 Nov;43(16-17):1315-22. doi: 10.1016/j.clinbiochem.2010.08.010. Epub 2010 Aug 14. Clin Biochem. 2010. PMID: 20713037
A new combination of blood test and fibroscan for accurate non-invasive diagnosis of liver fibrosis stages in chronic hepatitis C.
Boursier J, de Ledinghen V, Zarski JP, Rousselet MC, Sturm N, Foucher J, Leroy V, Fouchard-Hubert I, Bertrais S, Gallois Y, Oberti F, Dib N, Calès P. Boursier J, et al. Among authors: de ledinghen v. Am J Gastroenterol. 2011 Jul;106(7):1255-63. doi: 10.1038/ajg.2011.100. Epub 2011 Apr 5. Am J Gastroenterol. 2011. PMID: 21468012 Free article. Clinical Trial.
Relative performances of FibroTest, Fibroscan, and biopsy for the assessment of the stage of liver fibrosis in patients with chronic hepatitis C: a step toward the truth in the absence of a gold standard.
Poynard T, de Ledinghen V, Zarski JP, Stanciu C, Munteanu M, Vergniol J, France J, Trifan A, Le Naour G, Vaillant JC, Ratziu V, Charlotte F; Fibrosis-TAGS group. Poynard T, et al. Among authors: de ledinghen v. J Hepatol. 2012 Mar;56(3):541-8. doi: 10.1016/j.jhep.2011.08.007. Epub 2011 Sep 1. J Hepatol. 2012. PMID: 21889468
Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan(®): validation in chronic hepatitis C.
Sasso M, Tengher-Barna I, Ziol M, Miette V, Fournier C, Sandrin L, Poupon R, Cardoso AC, Marcellin P, Douvin C, de Ledinghen V, Trinchet JC, Beaugrand M. Sasso M, et al. Among authors: de ledinghen v. J Viral Hepat. 2012 Apr;19(4):244-53. doi: 10.1111/j.1365-2893.2011.01534.x. Epub 2011 Oct 13. J Viral Hepat. 2012. PMID: 22404722
Determination of reliability criteria for liver stiffness evaluation by transient elastography.
Boursier J, Zarski JP, de Ledinghen V, Rousselet MC, Sturm N, Lebail B, Fouchard-Hubert I, Gallois Y, Oberti F, Bertrais S, Calès P; Multicentric Group from ANRS/HC/EP23 FIBROSTAR Studies. Boursier J, et al. Among authors: de ledinghen v. Hepatology. 2013 Mar;57(3):1182-91. doi: 10.1002/hep.25993. Epub 2013 Feb 4. Hepatology. 2013. PMID: 22899556 Free article. Clinical Trial.
Precise evaluation of liver histology by computerized morphometry shows that steatosis influences liver stiffness measured by transient elastography in chronic hepatitis C.
Boursier J, de Ledinghen V, Sturm N, Amrani L, Bacq Y, Sandrini J, Le Bail B, Chaigneau J, Zarski JP, Gallois Y, Leroy V, Al Hamany Z, Oberti F, Fouchard-Hubert I, Dib N, Bertrais S, Rousselet MC, Calès P; Multicentre group ANRS HC EP23 FIBROSTAR. Boursier J, et al. Among authors: de ledinghen v. J Gastroenterol. 2014 Mar;49(3):527-37. doi: 10.1007/s00535-013-0819-9. Epub 2013 May 17. J Gastroenterol. 2014. PMID: 23681425
Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTest™) and transient elastography (FibroScan®).
Poynard T, Vergniol J, Ngo Y, Foucher J, Munteanu M, Merrouche W, Colombo M, Thibault V, Schiff E, Brass CA, Albrecht JK, Rudler M, Deckmyn O, Lebray P, Thabut D, Ratziu V, de Ledinghen V; FibroFrance Study Group; Epic3 Study Group; Bordeaux HCV Study Group. Poynard T, et al. Among authors: de ledinghen v. J Hepatol. 2014 Apr;60(4):706-14. doi: 10.1016/j.jhep.2013.11.016. Epub 2013 Nov 26. J Hepatol. 2014. PMID: 24291240
Staging chronic hepatitis B into seven categories, defining inactive carriers and assessing treatment impact using a fibrosis biomarker (FibroTest®) and elastography (FibroScan®).
Poynard T, Vergniol J, Ngo Y, Foucher J, Thibault V, Munteanu M, Merrouche W, Lebray P, Rudler M, Deckmyn O, Perazzo H, Thabut D, Ratziu V, de Ledinghen V; FibroFrance Study Group and the Bordeaux HBV Study Group. Poynard T, et al. Among authors: de ledinghen v. J Hepatol. 2014 Nov;61(5):994-1003. doi: 10.1016/j.jhep.2014.06.027. Epub 2014 Jul 10. J Hepatol. 2014. PMID: 25016224
An extension of STARD statements for reporting diagnostic accuracy studies on liver fibrosis tests: the Liver-FibroSTARD standards.
Boursier J, de Ledinghen V, Poynard T, Guéchot J, Carrat F, Leroy V, Wong GL, Friedrich-Rust M, Fraquelli M, Plebani M, Sebastiani G, Myers R, Angulo P, Bertrais S, Wendum D, Bricault I, Calès P; ARDENT group; AFEF. Boursier J, et al. Among authors: de ledinghen v. J Hepatol. 2015 Apr;62(4):807-15. doi: 10.1016/j.jhep.2014.10.042. Epub 2014 Nov 5. J Hepatol. 2015. PMID: 25450206 Free article.
MR relaxometry in chronic liver diseases: Comparison of T1 mapping, T2 mapping, and diffusion-weighted imaging for assessing cirrhosis diagnosis and severity.
Cassinotto C, Feldis M, Vergniol J, Mouries A, Cochet H, Lapuyade B, Hocquelet A, Juanola E, Foucher J, Laurent F, De Ledinghen V. Cassinotto C, et al. Among authors: de ledinghen v. Eur J Radiol. 2015 Aug;84(8):1459-1465. doi: 10.1016/j.ejrad.2015.05.019. Epub 2015 May 19. Eur J Radiol. 2015. PMID: 26032126
Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease.
Boursier J, Vergniol J, Guillet A, Hiriart JB, Lannes A, Le Bail B, Michalak S, Chermak F, Bertrais S, Foucher J, Oberti F, Charbonnier M, Fouchard-Hubert I, Rousselet MC, Calès P, de Lédinghen V. Boursier J, et al. Among authors: de ledinghen v. J Hepatol. 2016 Sep;65(3):570-8. doi: 10.1016/j.jhep.2016.04.023. Epub 2016 May 2. J Hepatol. 2016. PMID: 27151181
EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Short Version).
Dietrich CF, Bamber J, Berzigotti A, Bota S, Cantisani V, Castera L, Cosgrove D, Ferraioli G, Friedrich-Rust M, Gilja OH, Goertz RS, Karlas T, de Knegt R, de Ledinghen V, Piscaglia F, Procopet B, Saftoiu A, Sidhu PS, Sporea I, Thiele M. Dietrich CF, et al. Among authors: de knegt r, de ledinghen v. Ultraschall Med. 2017 Aug;38(4):377-394. doi: 10.1055/s-0043-103955. Epub 2017 Apr 13. Ultraschall Med. 2017. PMID: 28407654 Free article. English.
EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Long Version).
Dietrich CF, Bamber J, Berzigotti A, Bota S, Cantisani V, Castera L, Cosgrove D, Ferraioli G, Friedrich-Rust M, Gilja OH, Goertz RS, Karlas T, de Knegt R, de Ledinghen V, Piscaglia F, Procopet B, Saftoiu A, Sidhu PS, Sporea I, Thiele M. Dietrich CF, et al. Among authors: de knegt r, de ledinghen v. Ultraschall Med. 2017 Aug;38(4):e16-e47. doi: 10.1055/s-0043-103952. Epub 2017 Apr 13. Ultraschall Med. 2017. PMID: 28407655 Free article. English.
Impact of controlled attenuation parameter on detecting fibrosis using liver stiffness measurement.
Karlas T, Petroff D, Sasso M, Fan JG, Mi YQ, de Lédinghen V, Kumar M, Lupsor-Platon M, Han KH, Cardoso AC, Ferraioli G, Chan WK, Wong VW, Myers RP, Chayama K, Friedrich-Rust M, Beaugrand M, Shen F, Hiriart JB, Sarin SK, Badea R, Lee HW, Marcellin P, Filice C, Mahadeva S, Wong GL, Crotty P, Masaki K, Bojunga J, Bedossa P, Keim V, Wiegand J. Karlas T, et al. Among authors: de ledinghen v. Aliment Pharmacol Ther. 2018 Apr;47(7):989-1000. doi: 10.1111/apt.14529. Epub 2018 Feb 15. Aliment Pharmacol Ther. 2018. PMID: 29446106
Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis.
Petta S, Sebastiani G, Bugianesi E, Viganò M, Wong VW, Berzigotti A, Fracanzani AL, Anstee QM, Marra F, Barbara M, Calvaruso V, Cammà C, Di Marco V, Craxì A, de Ledinghen V. Petta S, et al. Among authors: de ledinghen v. J Hepatol. 2018 Oct;69(4):878-885. doi: 10.1016/j.jhep.2018.05.019. Epub 2018 May 24. J Hepatol. 2018. PMID: 29802949 Free article.
Range of Normal Liver Stiffness and Factors Associated With Increased Stiffness Measurements in Apparently Healthy Individuals.
Bazerbachi F, Haffar S, Wang Z, Cabezas J, Arias-Loste MT, Crespo J, Darwish-Murad S, Ikram MA, Olynyk JK, Gan E, Petta S, Berzuini A, Prati D, de Lédinghen V, Wong VW, Del Poggio P, Chávez-Tapia NC, Chen YP, Cheng PN, Yuen MF, Das K, Chowdhury A, Caballeria L, Fabrellas N, Ginès P, Kumar M, Sarin SK, Conti F, Andreone P, Sirli R, Cortez-Pinto H, Carvalhana S, Sugihara T, Kim SU, Parikh P, Chayama K, Corpechot C, Kim KM, Papatheodoridis G, Alsebaey A, Kamath PS, Murad MH, Watt KD. Bazerbachi F, et al. Among authors: de ledinghen v. Clin Gastroenterol Hepatol. 2019 Jan;17(1):54-64.e1. doi: 10.1016/j.cgh.2018.08.069. Epub 2018 Sep 7. Clin Gastroenterol Hepatol. 2019. PMID: 30196155
Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients With Compensated Cirrhosis and a Sustained Response to Antiviral Therapy.
Thabut D, Bureau C, Layese R, Bourcier V, Hammouche M, Cagnot C, Marcellin P, Guyader D, Pol S, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki JP, Zarski JP, Goria O, Calès P, Péron JM, Alric L, Bourlière M, Mathurin P, Blanc JF, Abergel A, Serfaty L, Mallat A, Grangé JD, Attali P, Bacq Y, Wartelle-Bladou C, Dao T, Pilette C, Silvain C, Christidis C, Capron D, Bernard-Chabert B, Hillaire S, Di Martino V, Sutton A, Audureau E, Roudot-Thoraval F, Nahon P; ANRS CO12 CirVir group. Thabut D, et al. Among authors: de ledinghen v. Gastroenterology. 2019 Mar;156(4):997-1009.e5. doi: 10.1053/j.gastro.2018.11.053. Epub 2019 Feb 13. Gastroenterology. 2019. PMID: 30768988
Including Ratio of Platelets to Liver Stiffness Improves Accuracy of Screening for Esophageal Varices That Require Treatment.
Berger A, Ravaioli F, Farcau O, Festi D, Stefanescu H, Buisson F, Nahon P, Bureau C, Ganne-Carriè N, Berzigotti A, de Ledinghen V, Petta S, Calès P; multicenter groups Varices œsophagiennes - Vidéo-capsule œsophagienne, Agence Nationale de Recherches sur le Sida et les Hépatites Virales, Cohort 12 Cirrhoses Virales, M116, and Validation of Expanded Baveno VI Criteria. Berger A, et al. Among authors: de ledinghen v. Clin Gastroenterol Hepatol. 2021 Apr;19(4):777-787.e17. doi: 10.1016/j.cgh.2020.06.022. Epub 2020 Jun 17. Clin Gastroenterol Hepatol. 2021. PMID: 32562889
Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver Disease.
Petta S, Sebastiani G, Viganò M, Ampuero J, Wai-Sun Wong V, Boursier J, Berzigotti A, Bugianesi E, Fracanzani AL, Cammà C, Enea M, Grottes MD, Di Marco V, Younes R, Keyrouz A, Mazzola S, Mendoza Y, Pennisi G, Romero-Gomez M, Craxì A, de Ledinghen V. Petta S, et al. Among authors: de ledinghen v. Clin Gastroenterol Hepatol. 2021 Apr;19(4):806-815.e5. doi: 10.1016/j.cgh.2020.06.045. Epub 2020 Jul 2. Clin Gastroenterol Hepatol. 2021. PMID: 32621970 Free article.
Two-dimensional shear wave elastography predicts survival in advanced chronic liver disease.
Trebicka J, Gu W, de Ledinghen V, Aubé C, Krag A, Praktiknjo M, Castera L, Dumortier J, Bauer DJM, Friedrich-Rust M, Pol S, Grgurevic I, Zheng R, Francque S, Gottfriedovà H, Mustapic S, Sporea I, Berzigotti A, Uschner FE, Simbrunner B, Ronot M, Cassinotto C, Kjaergaard M, Andrade F, Schulz M, Semmler G, Drinkovic IT, Chang J, Brol MJ, Rautou PE, Vanwolleghem T, Strassburg CP, Boursier J, Ferstl PG, Rasmussen DN, Reiberger T, Vilgrain V, Guibal A, Guillaud O, Zeuzem S, Vassord C, Lu X, Vonghia L, Senkerikova R, Popescu A, Margini C, Wang W, Thiele M, Jansen C. Trebicka J, et al. Among authors: de ledinghen v. Gut. 2022 Feb;71(2):402-414. doi: 10.1136/gutjnl-2020-323419. Epub 2021 Jan 21. Gut. 2022. PMID: 33479052 Free PMC article.
Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis.
Mózes FE, Lee JA, Selvaraj EA, Jayaswal ANA, Trauner M, Boursier J, Fournier C, Staufer K, Stauber RE, Bugianesi E, Younes R, Gaia S, Lupșor-Platon M, Petta S, Shima T, Okanoue T, Mahadeva S, Chan WK, Eddowes PJ, Hirschfield GM, Newsome PN, Wong VW, de Ledinghen V, Fan J, Shen F, Cobbold JF, Sumida Y, Okajima A, Schattenberg JM, Labenz C, Kim W, Lee MS, Wiegand J, Karlas T, Yılmaz Y, Aithal GP, Palaniyappan N, Cassinotto C, Aggarwal S, Garg H, Ooi GJ, Nakajima A, Yoneda M, Ziol M, Barget N, Geier A, Tuthill T, Brosnan MJ, Anstee QM, Neubauer S, Harrison SA, Bossuyt PM, Pavlides M; LITMUS Investigators. Mózes FE, et al. Among authors: de ledinghen v. Gut. 2022 May;71(5):1006-1019. doi: 10.1136/gutjnl-2021-324243. Epub 2021 May 17. Gut. 2022. PMID: 34001645 Free PMC article.
Non-invasive diagnosis and follow-up of portal hypertension.
Thabut D, Weil D, Bouzbib C, Rudler M, Cassinotto C, Castéra L, Serste T, Oberti F, Ganne-Carrié N, de Lédinghen V, Bourlière M, Bureau C. Thabut D, et al. Among authors: de ledinghen v. Clin Res Hepatol Gastroenterol. 2022 Oct;46(8):101767. doi: 10.1016/j.clinre.2021.101767. Epub 2021 Jul 29. Clin Res Hepatol Gastroenterol. 2022. PMID: 34332128
Non-invasive diagnosis and follow-up of chronic infection with Hepatitis C Virus.
Tran A, Shili-Masmoudi S, Moga L, Chevaliez S, Luciani A, Ruiz I, Ganne-Carrié N, Bureau C, Bourlière M, de Lédinghen V. Tran A, et al. Among authors: de ledinghen v. Clin Res Hepatol Gastroenterol. 2022 Jan;46(1):101771. doi: 10.1016/j.clinre.2021.101771. Epub 2021 Jul 28. Clin Res Hepatol Gastroenterol. 2022. PMID: 34332129
Non-invasive diagnosis and follow-up of non-alcoholic fatty liver disease.
Boursier J, Guillaume M, Bouzbib C, Lannes A, Pais R, Smatti S, Cariou B, Bureau C, Ganne-Carrié N, Bourlière M, de Lédinghen V. Boursier J, et al. Among authors: de ledinghen v. Clin Res Hepatol Gastroenterol. 2022 Jan;46(1):101769. doi: 10.1016/j.clinre.2021.101769. Epub 2021 Jul 28. Clin Res Hepatol Gastroenterol. 2022. PMID: 34332133
Liver-related and extrahepatic events in patients with non-alcoholic fatty liver disease: a retrospective competing risks analysis.
Pennisi G, Enea M, Romero-Gomez M, Viganò M, Bugianesi E, Wong VW, Fracanzani AL, Sebastiani G, Boursier J, Berzigotti A, Eslam M, Ampuero J, Benmassaoud A, La Mantia C, Mendoza YP, George J, Craxì A, Camma' C, de Ledinghen V, Petta S. Pennisi G, et al. Among authors: de ledinghen v. Aliment Pharmacol Ther. 2022 Mar;55(5):604-615. doi: 10.1111/apt.16763. Epub 2022 Jan 5. Aliment Pharmacol Ther. 2022. PMID: 34988994
A cholestatic pattern predicts major liver-related outcomes in patients with non-alcoholic fatty liver disease.
Pennisi G, Pipitone RM, Cabibi D, Enea M, Romero-Gomez M, Viganò M, Bugianesi E, Wong VW, Fracanzani AL, Sebastiani G, Berzigotti A, Di Salvo F, Giannone AG, La Mantia C, Lupo G, Porcasi R, Vernuccio F, Zito R, Di Marco V, Cammà C, Craxì A, de Ledinghen V, Grimaudo S, Petta S. Pennisi G, et al. Among authors: de ledinghen v. Liver Int. 2022 May;42(5):1037-1048. doi: 10.1111/liv.15232. Epub 2022 Mar 12. Liver Int. 2022. PMID: 35246921 Free article.
Impact of Type 2 Diabetes on the Accuracy of Noninvasive Tests of Liver Fibrosis With Resulting Clinical Implications.
Boursier J, Canivet CM, Costentin C, Lannes A, Delamarre A, Sturm N, Le Bail B, Michalak S, Oberti F, Hilleret MN, Irles-Depé M, Fouchard I, Hermabessiere P, Barthelon J, Calès P, Cariou B, de Ledinghen V, Roux M. Boursier J, et al. Among authors: de ledinghen v. Clin Gastroenterol Hepatol. 2023 May;21(5):1243-1251.e12. doi: 10.1016/j.cgh.2022.02.059. Epub 2022 Mar 11. Clin Gastroenterol Hepatol. 2023. PMID: 35288342
Comparison of screening strategies with two new tests to score and diagnose varices needing treatment.
Calès P, Ravaioli F, Berger A, Farcau O, Festi D, Stefanescu H, Vitellius C, Nahon P, Bureau C, Ganne-Carriè N, Berzigotti A, de Ledinghen V, Petta S. Calès P, et al. Among authors: de ledinghen v. Clin Res Hepatol Gastroenterol. 2022 Aug-Sep;46(7):101925. doi: 10.1016/j.clinre.2022.101925. Epub 2022 Apr 22. Clin Res Hepatol Gastroenterol. 2022. PMID: 35470108 Free article.
Validation of the new 2021 EASL algorithm for the noninvasive diagnosis of advanced fibrosis in NAFLD.
Canivet CM, Costentin C, Irvine KM, Delamarre A, Lannes A, Sturm N, Oberti F, Patel PJ, Decaens T, Irles-Depé M, Fouchard I, Hermabessière P, Roux M, Barthelon J, Calès P, Powell EE, de Ledinghen V, Boursier J. Canivet CM, et al. Among authors: de ledinghen v. Hepatology. 2023 Mar 1;77(3):920-930. doi: 10.1002/hep.32665. Epub 2023 Feb 17. Hepatology. 2023. PMID: 35822302
Practical diagnosis of cirrhosis in non-alcoholic fatty liver disease using currently available non-invasive fibrosis tests.
Boursier J, Roux M, Costentin C, Chaigneau J, Fournier-Poizat C, Trylesinski A, Canivet CM, Michalak S, Le Bail B, Paradis V, Bedossa P, Sturm N, de Ledinghen V; AFEF group for the study of liver fibrosis; M118 study group; Newsome PN. Boursier J, et al. Among authors: de ledinghen v. Nat Commun. 2023 Aug 26;14(1):5219. doi: 10.1038/s41467-023-40328-4. Nat Commun. 2023. PMID: 37633932 Free PMC article.
FibroTest and Fibroscan performances revisited in patients with chronic hepatitis C. Impact of the spectrum effect and the applicability rate.
Poynard T, de Ledinghen V, Zarski JP, Stanciu C, Munteanu M, Vergniol J, France J, Trifan A, Moussalli J, Lebray P, Thabut D, Ratziu V. Poynard T, et al. Among authors: de ledinghen v. Clin Res Hepatol Gastroenterol. 2011 Nov;35(11):720-30. doi: 10.1016/j.clinre.2011.07.003. Epub 2011 Aug 17. Clin Res Hepatol Gastroenterol. 2011. PMID: 21852224
Performances of Elasto-FibroTest(®), a combination between FibroTest(®) and liver stiffness measurements for assessing the stage of liver fibrosis in patients with chronic hepatitis C.
Poynard T, de Ledinghen V, Zarski JP, Stanciu C, Munteanu M, Vergniol J, France J, Trifan A, Lenaour G, Vaillant JC, Ratziu V, Charlotte F; Fibrosis-TAGS group. Poynard T, et al. Among authors: de ledinghen v. Clin Res Hepatol Gastroenterol. 2012 Oct;36(5):455-63. doi: 10.1016/j.clinre.2012.08.002. Epub 2012 Sep 5. Clin Res Hepatol Gastroenterol. 2012. PMID: 22959098
Longitudinal liver stiffness assessment in patients with chronic hepatitis C undergoing antiviral therapy.
Martinez SM, Foucher J, Combis JM, Métivier S, Brunetto M, Capron D, Bourlière M, Bronowicki JP, Dao T, Maynard-Muet M, Lucidarme D, Merrouche W, Forns X, de Lédinghen V. Martinez SM, et al. Among authors: de ledinghen v. PLoS One. 2012;7(10):e47715. doi: 10.1371/journal.pone.0047715. Epub 2012 Oct 17. PLoS One. 2012. PMID: 23082200 Free PMC article. Clinical Trial.
Improved fibrosis staging by elastometry and blood test in chronic hepatitis C.
Calès P, Boursier J, Ducancelle A, Oberti F, Hubert I, Hunault G, de Lédinghen V, Zarski JP, Salmon D, Lunel F; ANRS HC EP 23 Fibrostar Study. Calès P, et al. Among authors: de ledinghen v. Liver Int. 2014 Jul;34(6):907-17. doi: 10.1111/liv.12327. Epub 2013 Oct 16. Liver Int. 2014. PMID: 24102852
Increased liver stiffness is associated with mortality in HIV/HCV coinfected subjects: The French nationwide ANRS CO13 HEPAVIH cohort study.
Shili-Masmoudi S, Sogni P, de Ledinghen V, Esterle L, Valantin MA, Poizot-Martin I, Simon A, Rosenthal E, Lacombe K, Pialoux G, Bouchaud O, Gervais-Hasenknoff A, Goujard C, Piroth L, Zucman D, Dominguez S, Raffi F, Alric L, Bani-Sadr F, Lascoux-Combe C, Garipuy D, Miailhes P, Vittecoq D, Duvivier C, Aumaître H, Neau D, Morlat P, Dabis F, Salmon D, Wittkop L; ANRS CO13 HEPAVIH study group. Shili-Masmoudi S, et al. Among authors: de ledinghen v. PLoS One. 2019 Jan 25;14(1):e0211286. doi: 10.1371/journal.pone.0211286. eCollection 2019. PLoS One. 2019. PMID: 30682180 Free PMC article.
Prediction of Esophageal Varices by Liver Stiffness and Platelets in Persons With Human Immunodeficiency Virus Infection and Compensated Advanced Chronic Liver Disease.
Merchante N, Saroli Palumbo C, Mazzola G, Pineda JA, Téllez F, Rivero-Juárez A, Ríos-Villegas MJ, Maurice JB, Westbrook RH, Judge R, Guaraldi G, Schepis F, Perazzo H, Rockstroh J, Boesecke C, Klein MB, Cervo A, Ghali P, Wong P, Petta S, De Ledinghen V, Macías J, Sebastiani G. Merchante N, et al. Among authors: de ledinghen v. Clin Infect Dis. 2020 Dec 31;71(11):2810-2817. doi: 10.1093/cid/ciz1181. Clin Infect Dis. 2020. PMID: 31813962
Personalized surveillance for hepatocellular carcinoma in cirrhosis - using machine learning adapted to HCV status.
Audureau E, Carrat F, Layese R, Cagnot C, Asselah T, Guyader D, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki JP, Zarski JP, Riachi G, Calès P, Péron JM, Alric L, Bourlière M, Mathurin P, Blanc JF, Abergel A, Chazouillères O, Mallat A, Grangé JD, Attali P, d'Alteroche L, Wartelle C, Dao T, Thabut D, Pilette C, Silvain C, Christidis C, Nguyen-Khac E, Bernard-Chabert B, Zucman D, Di Martino V, Sutton A, Pol S, Nahon P; ANRS CO12 CirVir group. Audureau E, et al. Among authors: de ledinghen v. J Hepatol. 2020 Dec;73(6):1434-1445. doi: 10.1016/j.jhep.2020.05.052. Epub 2020 Jun 29. J Hepatol. 2020. PMID: 32615276
Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis.
Petroff D, Blank V, Newsome PN, Shalimar, Voican CS, Thiele M, de Lédinghen V, Baumeler S, Chan WK, Perlemuter G, Cardoso AC, Aggarwal S, Sasso M, Eddowes PJ, Allison M, Tsochatzis E, Anstee QM, Sheridan D, Cobbold JF, Naveau S, Lupsor-Platon M, Mueller S, Krag A, Irles-Depe M, Semela D, Wong GL, Wong VW, Villela-Nogueira CA, Garg H, Chazouillères O, Wiegand J, Karlas T. Petroff D, et al. Among authors: de ledinghen v. Lancet Gastroenterol Hepatol. 2021 Mar;6(3):185-198. doi: 10.1016/S2468-1253(20)30357-5. Epub 2021 Jan 16. Lancet Gastroenterol Hepatol. 2021. PMID: 33460567
Non-invasive diagnosis and follow-up of rare genetic liver diseases.
Sobesky R, Guillaud O, Bouzbib C, Sogni P, Poujois A, Woimant F, Duclos-Vallée JC, Bourlière M, de Lédinghen V, Ganne-Carrié N, Bureau C. Sobesky R, et al. Among authors: de ledinghen v. Clin Res Hepatol Gastroenterol. 2022 Jan;46(1):101768. doi: 10.1016/j.clinre.2021.101768. Epub 2021 Jul 29. Clin Res Hepatol Gastroenterol. 2022. PMID: 34332127
Non-invasive diagnosis and follow-up of chronic infection with hepatitis B virus.
Leroy V, Chevaliez S, Decraecker M, Roulot D, Nana J, Asselah T, Causse X, Durantel D, Thibaut V, Ganne-Carrié N, Bureau C, de Lédinghen V, Bourlière M. Leroy V, et al. Among authors: de ledinghen v. Clin Res Hepatol Gastroenterol. 2022 Oct;46(8):101773. doi: 10.1016/j.clinre.2021.101773. Epub 2021 Jul 28. Clin Res Hepatol Gastroenterol. 2022. PMID: 34332134
Non-invasive diagnosis and follow-up of primary biliary cholangitis.
Corpechot C, Heurgue A, Tanne F, Potier P, Hanslik B, Decraecker M, de Lédinghen V, Ganne-Carrié N, Bureau C, Bourlière M. Corpechot C, et al. Among authors: de ledinghen v. Clin Res Hepatol Gastroenterol. 2022 Jan;46(1):101770. doi: 10.1016/j.clinre.2021.101770. Epub 2021 Jul 28. Clin Res Hepatol Gastroenterol. 2022. PMID: 34332135
Non-invasive diagnosis and follow-up of primary malignant liver tumours.
Nahon P, Aubé C, Moga L, Chalaye J, Guiu B, Luciani A, Rode A, Ronot M, Seror O, Soussan M, Sutter O, Bourlière M, Bureau C, de Lédinghen V, Ganne-Carrié N. Nahon P, et al. Among authors: de ledinghen v. Clin Res Hepatol Gastroenterol. 2022 Jan;46(1):101766. doi: 10.1016/j.clinre.2021.101766. Epub 2021 Jul 29. Clin Res Hepatol Gastroenterol. 2022. PMID: 34332137
Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis.
Pageaux GP, Nzinga CL, Ganne N, Samuel D, Dorival C, Zoulim F, Cagnot C, Decaens T, Thabut D, Asselah T, Mathurin P, Habersetzer F, Bronowicki JP, Guyader D, Rosa I, Leroy V, Chazouilleres O, de Ledinghen V, Bourliere M, Causse X, Cales P, Metivier S, Loustaud-Ratti V, Riachi G, Alric L, Gelu-Simeon M, Minello A, Gournay J, Geist C, Tran A, Abergel A, Portal I, d'Alteroche L, Raffi F, Fontaine H, Carrat F, Pol S; French ANRS CO22 Hepather Cohort. Pageaux GP, et al. Among authors: de ledinghen v. BMC Infect Dis. 2022 Jan 27;22(1):94. doi: 10.1186/s12879-022-07076-0. BMC Infect Dis. 2022. PMID: 35086481 Free PMC article.
Prediction of hepatocellular carcinoma in Hepatitis C patients with advanced fibrosis after sustained virologic response.
Azzi J, Dorival C, Cagnot C, Fontaine H, Lusivika-Nzinga C, Leroy V, De Ledinghen V, Tran A, Zoulim F, Alric L, Gournay J, Bronowicki JP, Decaens T, Riachi G, Mikhail N, Soliman R, Shiha G, Pol S, Carrat F, Ganne-Carrié N; ANRS-AFEF Hepather Study group. Azzi J, et al. Among authors: de ledinghen v. Clin Res Hepatol Gastroenterol. 2022 Jun-Jul;46(6):101923. doi: 10.1016/j.clinre.2022.101923. Epub 2022 Apr 9. Clin Res Hepatol Gastroenterol. 2022. PMID: 35405354 Free article.
Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes.
Sasso M, Beaugrand M, de Ledinghen V, Douvin C, Marcellin P, Poupon R, Sandrin L, Miette V. Sasso M, et al. Among authors: de ledinghen v. Ultrasound Med Biol. 2010 Nov;36(11):1825-35. doi: 10.1016/j.ultrasmedbio.2010.07.005. Epub 2010 Sep 27. Ultrasound Med Biol. 2010. PMID: 20870345
Sofosbuvir-based treatment of hepatitis C with severe fibrosis (METAVIR F3/F4) after liver transplantation.
Dumortier J, Leroy V, Duvoux C, de Ledinghen V, Francoz C, Houssel-Debry P, Radenne S, d'Alteroche L, Fougerou-Leurent C, Canva V, di Martino V, Conti F, Kamar N, Moreno C, Lebray P, Tran A, Besch C, Diallo A, Rohel A, Rossignol E, Abergel A, Botta-Fridlund D, Coilly A, Samuel D, Duclos-Vallée JC, Pageaux GP. Dumortier J, et al. Among authors: de ledinghen v. Liver Transpl. 2016 Oct;22(10):1367-78. doi: 10.1002/lt.24505. Liver Transpl. 2016. PMID: 27348086 Free article. Clinical Trial.
12 Weeks of a Ribavirin-Free Sofosbuvir and Nonstructural Protein 5A Inhibitor Regimen Is Enough to Treat Recurrence of Hepatitis C After Liver Transplantation.
Houssel-Debry P, Coilly A, Fougerou-Leurent C, Jezequel C, Duvoux C, De Ledinghen V, Radenne S, Kamar N, Leroy V, Martino VD, D'Alteroche L, Canva V, Conti F, Dumortier J, Montialoux H, Lebray P, Botta-Fridlund D, Tran A, Moreno C, Silvain C, Besch C, Perre P, Francoz C, Abergel A, Habersetzer F, Debette-Gratien M, Cagnot C, Diallo A, Chevaliez S, Rossignol E, Veislinger A, Duclos-Vallee JC, Pageaux GP; the ANRS CO23 CUPILT study group. Houssel-Debry P, et al. Among authors: de ledinghen v. Hepatology. 2018 Oct;68(4):1277-1287. doi: 10.1002/hep.29918. Hepatology. 2018. PMID: 29633389 Clinical Trial.
Abdominal Surgery in Patients With Idiopathic Noncirrhotic Portal Hypertension: A Multicenter Retrospective Study.
Elkrief L, Ferrusquia-Acosta J, Payancé A, Moga L, Tellez L, Praktiknjo M, Procopet B, Farcau O, De Lédinghen V, Yuldashev R, Tabchouri N, Barbier L, Dumortier J, Menahem B, Magaz M, Hernández-Gea V, Albillos A, Trebicka J, Spahr L, De Gottardi A, Plessier A, Valla D, Rubbia-Brandt L, Toso C, Bureau C, Garcia-Pagan JC, Rautou PE; for VALDIG, an EASL consortium. Elkrief L, et al. Among authors: de gottardi a, de ledinghen v. Hepatology. 2019 Sep;70(3):911-924. doi: 10.1002/hep.30628. Epub 2019 May 21. Hepatology. 2019. PMID: 30924941 Free article.
Increased mortality in HIV/HCV-coinfected compared to HCV-monoinfected patients in the DAA era due to non-liver-related death.
Chalouni M, Pol S, Sogni P, Fontaine H, Lacombe K, Marc-Lacombe J, Esterle L, Dorival C, Bourlière M, Bani-Sadr F, de Ledinghen V, Zucman D, Larrey D, Salmon D, Carrat F, Wittkop L; ANRS CO13 HEPAVIH and ANRS CO22 HEPATHER cohort study groups. Chalouni M, et al. Among authors: de ledinghen v. J Hepatol. 2021 Jan;74(1):37-47. doi: 10.1016/j.jhep.2020.08.008. Epub 2020 Aug 14. J Hepatol. 2021. PMID: 32798585 Free article.
HCV Eradication in Primary or Secondary Prevention Optimizes Hepatocellular Carcinoma Curative Management.
Nahon P, Layese R, Cagnot C, Asselah T, Guyader D, Pol S, Pageaux GP, De Lédinghen V, Ouzan D, Zoulim F, Audureau E; ANRS CO12 CirVir group. Nahon P, et al. Among authors: de ledinghen v. Cancer Prev Res (Phila). 2021 May;14(5):581-592. doi: 10.1158/1940-6207.CAPR-20-0465. Epub 2021 Feb 19. Cancer Prev Res (Phila). 2021. PMID: 33608313 Clinical Trial.
Non-invasive diagnosis and follow-up of autoimmune hepatitis.
Lemoinne S, Heurgue A, Bouzbib C, Hanslik B, Gournay J, Nguyen-Khac E, Bureau C, de Lédinghen V, Ganne-Carrié N, Bourlière M. Lemoinne S, et al. Among authors: de ledinghen v. Clin Res Hepatol Gastroenterol. 2022 Jan;46(1):101772. doi: 10.1016/j.clinre.2021.101772. Epub 2021 Jul 28. Clin Res Hepatol Gastroenterol. 2022. PMID: 34332126 Review.
Non-invasive diagnosis and follow-up of benign liver tumours.
Nault JC, Blanc JF, Moga L, Calderaro J, Dao T, Guiu B, Hocquelet A, Paradis V, Salamé E, de Lédinghen V, Bourlière M, Bureau C, Ganne-Carrié N. Nault JC, et al. Among authors: de ledinghen v. Clin Res Hepatol Gastroenterol. 2022 Jan;46(1):101765. doi: 10.1016/j.clinre.2021.101765. Epub 2021 Jul 29. Clin Res Hepatol Gastroenterol. 2022. PMID: 34333196
Paroxysmal nocturnal hemoglobinuria and vascular liver disease: Eculizumab therapy decreases mortality and thrombotic complications.
Plessier A, Esposito-Farèse M, Baiges A, Shukla A, Garcia Pagan JC, De Raucourt E, Ollivier-Hourmand I, Cervoni JP, De Ledinghen V, Tazi Z, Nousbaum JB, Bun R, Bureau C, Silvain C, Tournilhac O, Gerfaud-Valentin M, Durand F, Goria O, Tellez L, Albillos A, Gioia S, Riggio O, De Gottardi A, Payance A, Rautou PE, Terriou L, Charbonnier A, Elkrief L, de la Tour RP, Valla DC, Gault N, de Fontbrune FS. Plessier A, et al. Among authors: de gottardi a, de la tour rp, de raucourt e, de fontbrune fs, de ledinghen v. Am J Hematol. 2022 Apr;97(4):431-439. doi: 10.1002/ajh.26474. Epub 2022 Jan 31. Am J Hematol. 2022. PMID: 35049058 Free article.
Severe liver fibrosis in the HCV cure era: Major effects of social vulnerability, diabetes, and unhealthy behaviors.
Carrieri P, Carrat F, Di Beo V, Bourlière M, Barré T, De Ledinghen V, Pageaux GP, Bureau M, Cagnot C, Dorival C, Delarocque-Astagneau E, Marcellin F, Pol S, Fontaine H, Protopopescu C; ANRS CO22 HEPATHER study group. Carrieri P, et al. Among authors: de ledinghen v. JHEP Rep. 2022 Mar 30;4(6):100481. doi: 10.1016/j.jhepr.2022.100481. eCollection 2022 Jun. JHEP Rep. 2022. PMID: 35514789 Free PMC article.
Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications.
Nahon P, Bourcier V, Layese R, Audureau E, Cagnot C, Marcellin P, Guyader D, Fontaine H, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki JP, Zarski JP, Leroy V, Riachi G, Calès P, Péron JM, Alric L, Bourlière M, Mathurin P, Dharancy S, Blanc JF, Abergel A, Serfaty L, Mallat A, Grangé JD, Attali P, Bacq Y, Wartelle C, Dao T, Benhamou Y, Pilette C, Silvain C, Christidis C, Capron D, Bernard-Chabert B, Zucman D, Di Martino V, Thibaut V, Salmon D, Ziol M, Sutton A, Pol S, Roudot-Thoraval F; ANRS CO12 CirVir Group. Nahon P, et al. Among authors: de ledinghen v. Gastroenterology. 2017 Jan;152(1):142-156.e2. doi: 10.1053/j.gastro.2016.09.009. Epub 2016 Sep 15. Gastroenterology. 2017. PMID: 27641509
Extrahepatic cancers are the leading cause of death in patients achieving hepatitis B virus control or hepatitis C virus eradication.
Allaire M, Nahon P, Layese R, Bourcier V, Cagnot C, Marcellin P, Guyader D, Pol S, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki JP, Zarski JP, Riachi G, Calès P, Péron JM, Alric L, Bourlière M, Mathurin P, Blanc JF, Abergel A, Serfaty L, Mallat A, Grangé JD, Attali P, Bacq Y, Wartelle C, Dao T, Thabut D, Pilette C, Silvain C, Christidis C, Nguyen-Khac E, Bernard-Chabert B, Zucman D, DI Martino V, Sutton A, Letouzé E, Audureau E, Roudot-Thoraval F; ANRS CO12 CirVir Group. Allaire M, et al. Among authors: de ledinghen v. Hepatology. 2018 Oct;68(4):1245-1259. doi: 10.1002/hep.30034. Epub 2018 Jul 10. Hepatology. 2018. PMID: 29663511
Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study.
Costentin CE, Layese R, Bourcier V, Cagnot C, Marcellin P, Guyader D, Pol S, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki JP, Zarski JP, Riachi G, Calès P, Péron JM, Alric L, Bourlière M, Mathurin P, Blanc JF, Abergel A, Serfaty L, Mallat A, Grangé JD, Attali P, Bacq Y, Wartelle C, Dao T, Thabut D, Pilette C, Silvain C, Christidis C, Nguyen-Khac E, Bernard-Chabert B, Zucman D, Di Martino V, Sutton A, Letouzé E, Imbeaud S, Zucman-Rossi J, Audureau E, Roudot-Thoraval F, Nahon P; ANRS CO12 CirVir Group. Costentin CE, et al. Among authors: de ledinghen v. Gastroenterology. 2018 Aug;155(2):431-442.e10. doi: 10.1053/j.gastro.2018.04.027. Epub 2018 May 3. Gastroenterology. 2018. PMID: 29729258 Free article.
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study.
Carrat F, Fontaine H, Dorival C, Simony M, Diallo A, Hezode C, De Ledinghen V, Larrey D, Haour G, Bronowicki JP, Zoulim F, Asselah T, Marcellin P, Thabut D, Leroy V, Tran A, Habersetzer F, Samuel D, Guyader D, Chazouilleres O, Mathurin P, Metivier S, Alric L, Riachi G, Gournay J, Abergel A, Cales P, Ganne N, Loustaud-Ratti V, D'Alteroche L, Causse X, Geist C, Minello A, Rosa I, Gelu-Simeon M, Portal I, Raffi F, Bourliere M, Pol S; French ANRS CO22 Hepather cohort. Carrat F, et al. Among authors: de ledinghen v. Lancet. 2019 Apr 6;393(10179):1453-1464. doi: 10.1016/S0140-6736(18)32111-1. Epub 2019 Feb 11. Lancet. 2019. PMID: 30765123
Predictive factors for hepatocellular carcinoma in chronic hepatitis B using structural equation modeling: a prospective cohort study.
Lam L, Fontaine H, Bourliere M, Lusivika-Nzinga C, Dorival C, Thabut D, Zoulim F, Habersetzer F, Asselah T, Duclos-Vallee JC, Bronowicki JP, Mathurin P, Decaens T, Ganne N, Guyader D, Leroy V, Rosa I, De Ledinghen V, Cales P, Causse X, Larrey D, Chazouilleres O, Gelu-Simeon M, Loustaud-Ratti V, Metivier S, Alric L, Riachi G, Gournay J, Minello A, Tran A, Geist C, Abergel A, Raffi F, D'Alteroche L, Portal I, Lapidus N, Pol S, Carrat F; ANRS/AFEF Hepather study group. Lam L, et al. Among authors: de ledinghen v. Clin Res Hepatol Gastroenterol. 2021 Sep;45(5):101713. doi: 10.1016/j.clinre.2021.101713. Epub 2021 Apr 27. Clin Res Hepatol Gastroenterol. 2021. PMID: 33930591 Free article.
Non-invasive diagnosis and follow-up in liver transplantation.
Dumortier J, Besch C, Moga L, Coilly A, Conti F, Corpechot C, Del Bello A, Faitot F, Francoz C, Hilleret MN, Houssel-Debry P, Jezequel C, Lavayssière L, Neau-Cransac M, Erard-Poinsot D, de Lédinghen V, Bourlière M, Bureau C, Ganne-Carrié N. Dumortier J, et al. Among authors: de ledinghen v. Clin Res Hepatol Gastroenterol. 2022 Jan;46(1):101774. doi: 10.1016/j.clinre.2021.101774. Epub 2021 Jul 28. Clin Res Hepatol Gastroenterol. 2022. PMID: 34332131
Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease.
Lin H, Lee HW, Yip TC, Tsochatzis E, Petta S, Bugianesi E, Yoneda M, Zheng MH, Hagström H, Boursier J, Calleja JL, Goh GB, Chan WK, Gallego-Durán R, Sanyal AJ, de Lédinghen V, Newsome PN, Fan JG, Castéra L, Lai M, Harrison SA, Fournier-Poizat C, Wong GL, Pennisi G, Armandi A, Nakajima A, Liu WY, Shang Y, de Saint-Loup M, Llop E, Teh KK, Lara-Romero C, Asgharpour A, Mahgoub S, Chan MS, Canivet CM, Romero-Gomez M, Kim SU, Wong VW; VCTE-Prognosis Study Group. Lin H, et al. Among authors: de ledinghen v. JAMA. 2024 Apr 16;331(15):1287-1297. doi: 10.1001/jama.2024.1447. JAMA. 2024. PMID: 38512249
Anti-inflammatory drugs and variceal bleeding: a case-control study.
De Lédinghen V, Heresbach D, Fourdan O, Bernard P, Liebaert-Bories MP, Nousbaum JB, Gourlaouen A, Becker MC, Ribard D, Ingrand P, Silvain C, Beauchant M. De Lédinghen V, et al. Gut. 1999 Feb;44(2):270-3. doi: 10.1136/gut.44.2.270. Gut. 1999. PMID: 9895389 Free PMC article.
[Natural history of hepatitis C virus infection].
de Lédinghen V. de Lédinghen V. Gastroenterol Clin Biol. 2002 Apr;26 Spec No 2:B9-22. Gastroenterol Clin Biol. 2002. PMID: 12180313 Review. French. No abstract available.
Variability of the area under the receiver operating characteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentation.
Poynard T, Halfon P, Castera L, Charlotte F, Le Bail B, Munteanu M, Messous D, Ratziu V, Benhamou Y, Bourlière M, De Ledinghen V; FibroPaca Group. Poynard T, et al. Among authors: de ledinghen v. Aliment Pharmacol Ther. 2007 Mar 15;25(6):733-9. doi: 10.1111/j.1365-2036.2007.03252.x. Aliment Pharmacol Ther. 2007. PMID: 17311607 Free article.
Evaluation and improvement of a reliable diagnosis of cirrhosis by blood tests.
Calès P, Boursier J, de Lédinghen V, Halfon P, Bacq Y, Leroy V, Dib N, Oberti F, Sawadogo A, Rousselet MC, Lunel F. Calès P, et al. Among authors: de ledinghen v. Gastroenterol Clin Biol. 2008 Dec;32(12):1050-60. doi: 10.1016/j.gcb.2008.09.017. Epub 2008 Nov 18. Gastroenterol Clin Biol. 2008. PMID: 19019606 Free article.
Prognostic value of viral eradication for major adverse cardiovascular events in hepatitis C cirrhotic patients.
Cacoub P, Nahon P, Layese R, Blaise L, Desbois AC, Bourcier V, Cagnot C, Marcellin P, Guyader D, Pol S, Larrey D, De Lédinghen V, Ouzan D, Zoulim F, Roulot D, Tran A, Bronowicki JP, Zarski JP, Riachi G, Calès P, Péron JM, Alric L, Bourlière M, Mathurin P, Blanc JF, Abergel A, Serfaty L, Mallat A, Grangé JD, Attali P, Bacq Y, Wartelle C, Dao T, Thabut D, Pilette C, Silvain C, Christidis C, Capron D, Thiefin G, Zucman D, Di Martino V, Bagnis CI, Ziol M, Sutton A, Letouze E, Roudot-Thoraval F, Audureau E; ANRS CO12 CirVir group. Cacoub P, et al. Among authors: de ledinghen v. Am Heart J. 2018 Apr;198:4-17. doi: 10.1016/j.ahj.2017.10.024. Epub 2017 Nov 7. Am Heart J. 2018. PMID: 29653647
Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis.
Ganne-Carrié N, Chaffaut C, Bourcier V, Archambeaud I, Perarnau JM, Oberti F, Roulot D, Moreno C, Louvet A, Dao T, Moirand R, Goria O, Nguyen-Khac E, Carbonell N, Antonini T, Pol S, de Ledinghen V, Ozenne V, Henrion J, Péron JM, Tran A, Perlemuter G, Amiot X, Zarski JP, Beaugrand M, Chevret S; for CIRRAL Group. Ganne-Carrié N, et al. Among authors: de ledinghen v. J Hepatol. 2018 Dec;69(6):1274-1283. doi: 10.1016/j.jhep.2018.07.022. Epub 2018 Aug 6. J Hepatol. 2018. PMID: 30092234 Free article.
A consensus integrated care pathway for patients with primary biliary cholangitis: a guideline-based approach to clinical care of patients.
Hirschfield GM, Chazouillères O, Cortez-Pinto H, Macedo G, de Lédinghen V, Adekunle F, Carbone M. Hirschfield GM, et al. Among authors: de ledinghen v. Expert Rev Gastroenterol Hepatol. 2021 Aug;15(8):929-939. doi: 10.1080/17474124.2021.1945919. Epub 2021 Jul 7. Expert Rev Gastroenterol Hepatol. 2021. PMID: 34233565
Non-invasive diagnosis and follow-up of primary sclerosing cholangitis.
Chazouillères O, Potier P, Bouzbib C, Hanslik B, Heurgue A, NGuyen-Khac E, Gournay J, Tanne F, Bureau C, Bourlière M, Ganne-Carrié N, de Lédinghen V. Chazouillères O, et al. Among authors: de ledinghen v. Clin Res Hepatol Gastroenterol. 2022 Jan;46(1):101775. doi: 10.1016/j.clinre.2021.101775. Epub 2021 Jul 28. Clin Res Hepatol Gastroenterol. 2022. PMID: 34332142
ABO blood group does not influence Child-Pugh A cirrhosis outcome: An observational study from CIRRAL and ANRS CO12 CIRVIR cohorts.
Ollivier-Hourmand I, Repesse Y, Nahon P, Chaffaut C, Dao T, Nguyen TTN, Marcellin P, Roulot D, De Ledinghen V, Pol S, Guyader D, Archambeaud I, Zoulim F, Oberti F, Tran A, Bronowicki JP, D'Alteroche L, Ouzan D, Peron JM, Zarski JP, Bourliere M, Larrey D, Louvet A, Cales P, Abergel A, Mathurin P, Mallat A, Blanc JF, Nguyen-Khac E, Riachi G, Alric L, Serfaty L, Antonini T, Moreno C, Attali P, Thabut D, Pilette C, Grange JD, Silvain C, Carbonell N, Bernard-Chabert B, Goria O, Wartelle C, Moirand R, Christidis C, Perlemuter G, Ozenne V, Henrion J, Hillaire S, Di Martino V, Amiot X, Sutton A, Barget N, Chevret S, Ganne-Carrie N; ANRS CO12 CIRVIR, CIRRAL groups. Ollivier-Hourmand I, et al. Among authors: de ledinghen v. Liver Int. 2022 Jun;42(6):1386-1400. doi: 10.1111/liv.15159. Epub 2022 Jan 17. Liver Int. 2022. PMID: 35025128
Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis.
Mózes FE, Lee JA, Vali Y, Alzoubi O, Staufer K, Trauner M, Paternostro R, Stauber RE, Holleboom AG, van Dijk AM, Mak AL, Boursier J, de Saint Loup M, Shima T, Bugianesi E, Gaia S, Armandi A, Shalimar, Lupșor-Platon M, Wong VW, Li G, Wong GL, Cobbold J, Karlas T, Wiegand J, Sebastiani G, Tsochatzis E, Liguori A, Yoneda M, Nakajima A, Hagström H, Akbari C, Hirooka M, Chan WK, Mahadeva S, Rajaram R, Zheng MH, George J, Eslam M, Petta S, Pennisi G, Viganò M, Ridolfo S, Aithal GP, Palaniyappan N, Lee DH, Ekstedt M, Nasr P, Cassinotto C, de Lédinghen V, Berzigotti A, Mendoza YP, Noureddin M, Truong E, Fournier-Poizat C, Geier A, Martic M, Tuthill T, Anstee QM, Harrison SA, Bossuyt PM, Pavlides M; LITMUS investigators. Mózes FE, et al. Among authors: de saint loup m, de ledinghen v. Lancet Gastroenterol Hepatol. 2023 Aug;8(8):704-713. doi: 10.1016/S2468-1253(23)00141-3. Epub 2023 Jun 5. Lancet Gastroenterol Hepatol. 2023. PMID: 37290471 Free article.
[Hepatocellular carcinoma in the non-cirrhotic liver: renewed interest].
Bernard PH, Blanc JF, Le Bail B, de Ledinghen V, Rullier A, Balabaud C, Bioulac-Sage P. Bernard PH, et al. Among authors: de ledinghen v. Gastroenterol Clin Biol. 1998 Apr;22(4):371-4. Gastroenterol Clin Biol. 1998. PMID: 9762265 Free article. Review. French. No abstract available.
TT virus infection during chronic hepatitis C.
Trimoulet P, de Lédinghen V, Ekouevi D, Bernard PH, Merel P, Chêne G, Couzigou P, Fleury H. Trimoulet P, et al. Among authors: de ledinghen v. Am J Gastroenterol. 2000 Jul;95(7):1765-9. doi: 10.1111/j.1572-0241.2000.02138.x. Am J Gastroenterol. 2000. PMID: 10925982
[Chronic viral hepatitis C: current therapy and perspectives].
Couzigou P, De Ledinghen V, Foucher J. Couzigou P, et al. Among authors: de ledinghen v. Gastroenterol Clin Biol. 2001 Apr;25(4 Suppl):B135-42. Gastroenterol Clin Biol. 2001. PMID: 11449154 Free article. Review. French. No abstract available.
Daily or three times a week interferon alfa-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C.
de Lédinghen V, Trimoulet P, Winnock M, Foucher J, Bourlière M, Desmorat H, Canva V, Capron D, Lévy S, Mion F, Mannant PR, Chêne G, Fleury H, Couzigou P, Bernard PH; French Multicenter Study Group. de Lédinghen V, et al. J Hepatol. 2002 May;36(5):672-80. doi: 10.1016/s0168-8278(02)00026-0. J Hepatol. 2002. PMID: 11983451 Clinical Trial.
Daily or three times per week interferon alpha-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C not responding to previous interferon alone.
de Lédinghen V, Trimoulet P, Winnock M, Bernard PH, Bourlière M, Portal I, Rémy AJ, Szostak N, Lévy S, Tran A, Abergel A, Chêne G, Fleury H, Couzigou P; French Multicenter Study Group. de Lédinghen V, et al. J Hepatol. 2002 Jun;36(6):819-26. doi: 10.1016/s0168-8278(02)00071-5. J Hepatol. 2002. PMID: 12044534 Clinical Trial.
Retreatment with interferon and ribavirin vs interferon alone according to viraemia in interferon responder-relapser hepatitis C patients: a prospective multicentre randomized controlled study.
Portal I, Bourlière M, Halfon P, De Lédinghen V, Couzigou P, Bernard PH, Blanc F, Caroli-Bosc F, Arpurt JP, Vetter D, Mathieu-Chandelier C, Chazouillères O, Thiefin G, Pol S, Sogni P, Abergel A, Bailly F, Picon M, Debonne JM, Zamora C, Alleman I, Moreau X, Doll F, Eugène C, Ducloux S, Larrey D, Ouzan D, Grimaud JC, Gouvernet J, Botti G, Gérolami V, Khiri H, Gérolami A, Gauthier AP, Botta-Fridlund D. Portal I, et al. Among authors: de ledinghen v. J Viral Hepat. 2003 May;10(3):215-23. doi: 10.1046/j.1365-2893.2003.00426.x. J Viral Hepat. 2003. PMID: 12753341 Clinical Trial.
Histological response in patients treated by interferon plus ribavirin for hepatitis C virus-related severe fibrosis.
Abergel A, Darcha C, Chevallier M, Ughetto S, Henquell C, Pol S, de Ledinghen V, Canva V, Bronowicki JP, Tran A, Martineau N, Lafeuille H, Dechelotte P, Bommelaer G, Bonny C; French Multicentre Study Group. Abergel A, et al. Among authors: de ledinghen v. Eur J Gastroenterol Hepatol. 2004 Nov;16(11):1219-27. doi: 10.1097/00042737-200411000-00022. Eur J Gastroenterol Hepatol. 2004. PMID: 15489585 Clinical Trial.
Paroxysmal nocturnal hemoglobinuria and Budd-Chiari syndrome: therapeutic challenge with bone marrow transplantation, transjugular intrahepatic portosystemic shunt, and vena cava stent.
Vergniol J, Laharie D, Drouillard J, Etienne G, Pigneux A, Plessier A, Couzigou P, de Lédinghen V. Vergniol J, et al. Among authors: de ledinghen v. Eur J Gastroenterol Hepatol. 2005 Apr;17(4):453-6. doi: 10.1097/00042737-200504000-00011. Eur J Gastroenterol Hepatol. 2005. PMID: 15756100 Review.
409 results